Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia
Clinical trial NCT05611528 · COMPLETED
Trial details
- NCT number
- NCT05611528
- Sponsor
- Daniel Gaudet
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-12-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.